GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (XCNQ:CL) » Definitions » Cyclically Adjusted PB Ratio

Cresco Labs (XCNQ:CL) Cyclically Adjusted PB Ratio : (As of May. 17, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Cresco Labs Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cresco Labs Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Cresco Labs's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cresco Labs Cyclically Adjusted PB Ratio Chart

Cresco Labs Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cresco Labs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cresco Labs's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cresco Labs's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cresco Labs's Cyclically Adjusted PB Ratio falls into.



Cresco Labs Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Cresco Labs's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Cresco Labs's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.997/129.4194*129.4194
=1.997

Current CPI (Dec. 2023) = 129.4194.

Cresco Labs Quarterly Data

Book Value per Share CPI Adj_Book
201401 -27.664 98.692 -36.277
201404 -28.900 100.023 -37.394
201407 -29.158 100.520 -37.541
201410 -30.451 100.176 -39.340
201501 -30.968 98.604 -40.646
201504 -34.099 99.824 -44.209
201507 -29.158 100.691 -37.477
201510 -29.905 100.346 -38.569
201601 -31.112 99.957 -40.282
201604 -31.801 100.947 -40.771
201607 -31.830 101.524 -40.576
201610 -31.744 101.988 -40.282
201701 -34.875 102.456 -44.053
201704 -34.674 103.167 -43.497
201707 -36.455 103.278 -45.682
201710 -35.651 104.070 -44.335
201801 -37.978 104.578 -46.999
201804 -38.150 105.708 -46.707
201807 -34.444 106.324 -41.926
201810 -0.317 106.695 -0.385
201903 1.440 107.251 1.738
201906 1.367 108.070 1.637
201909 1.760 108.329 2.103
201912 1.873 108.420 2.236
202003 4.235 108.902 5.033
202006 3.891 108.767 4.630
202009 3.735 109.815 4.402
202012 2.713 109.897 3.195
202103 3.167 111.754 3.668
202106 4.032 114.631 4.552
202109 3.101 115.734 3.468
202112 3.327 117.630 3.660
202203 3.138 121.301 3.348
202206 3.425 125.017 3.546
202209 3.497 125.227 3.614
202212 2.828 125.222 2.923
202303 2.753 127.348 2.798
202306 2.463 128.729 2.476
202309 2.029 129.860 2.022
202312 1.997 129.419 1.997

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cresco Labs  (XCNQ:CL) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Cresco Labs Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Cresco Labs's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cresco Labs (XCNQ:CL) Business Description

Traded in Other Exchanges
Address
400 W. Erie Street, Suite 110, Chicago, IL, USA, 60654
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and third-party retail stores. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.